ProMIS Neurosciences, Inc. (PMN)
NASDAQ: PMN · Real-Time Price · USD
13.30
-0.71 (-5.07%)
Jul 16, 2026, 4:00 PM EDT - Market closed
ProMIS Neurosciences Stock Forecast
Stock Price Forecast
According to 7 analysts polled by S&P Global, ProMIS Neurosciences stock has a consensus rating of "Strong Buy" and an average price target of $32.49. The average 1-year stock price forecast is 144.28% higher than the current stock price, while the lowest is $18.16 (+36.54%) and the highest is $48.32 (+263.31%).
Price Target: $32.49 (+144.28%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for ProMIS Neurosciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Feb '26 | Mar '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 3 | 4 | 5 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 5 | 6 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $18 | Buy | Reiterates | $18 | +35.34% | Jul 15, 2026 |
Unknown Analyst Guggenheim No rating | Guggenheim | Buy Maintains $35 | Buy | Maintains | $35 | +163.16% | Jul 14, 2026 |
| Roth MKM | Roth MKM | Buy Initiates $19 | Buy | Initiates | $19 | +42.86% | Jul 7, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $40 | Buy | Initiates | $40 | +198.87% | Jun 30, 2026 |
Unknown Analyst Brookline Capital Markets No rating | Brookline Capital Markets | Buy Initiates $40 | Buy | Initiates | $40 | +200.75% | May 20, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-5.86
EPS Next Year
-2.41
from -5.86
EPS and Forward PE are based on non-GAAP adjusted numbers.